[1]孙文婷,郑丹妮,杨爱娟,等.男性强直性脊柱炎患者中医证型与骨密度关系及低骨密度危险因素分析[J].中国中医药信息杂志,2020,27(9):35-40.[doi:10.3969/j.issn.1005-5304.202005066]
 SUN Wenting,ZHENG Danni,YANG Aijuan,et al.Relationship Between TCM Syndromes and Bone Mineral Density in Male Patients with Ankylosing Spondylitis and Analysis on Risk Factors of Low Bone Mineral Density[J].zhongguo zhongyiyao xinxi zazhi,2020,27(9):35-40.[doi:10.3969/j.issn.1005-5304.202005066]
点击复制

男性强直性脊柱炎患者中医证型与骨密度关系及低骨密度危险因素分析

参考文献/References:

[1] WARD M M, DEODHAR A, GENSLER L S, et al. 2019 update of the American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis[J]. Arthritis Rheumatol, 2019,71(10):1599-1613.

[2] MALOCHET-GUINAMAND S, PEREIRA B, TATAR Z, et al. Prevalence and risk factors of low bone mineral density in spondyloarthritis and prevalence of vertebral fractures[J]. BMC Musculoskelet Disord, 2017,18(1):357.

[3] HU L Y, LU T, CHEN P M, et al. Should clinicians pay more attention to the potential underdiagnosis of osteoporosis in patients with ankylosing spondylitis? A national population-based study in Taiwan[J]. PLoS One,2019,14(2):e0211835.

[4] ULU M A, BATMAZ ?/span>, DILEK B, et al. Prevalence of osteoporosis and vertebral fractures and related factors in patients with ankylosing spondylitis[J]. Chin Med J (Engl),2014,127(15)2740-2747.

[5] VAN DER WEIJDEN M A, VAN DENDEREN J C, LEMS W F, et al. Low bone mineral density is related to male gender and decreased functional capacity in early spondylarthropathies[J]. Clin Rheumatol,2011, 30(4):497-503.

[6] PRAY C, FEROZ N I, NIGIL H N. Bone mineral density and fracture risk in ankylosing spondylitis:a meta-analysis[J]. Calcif Tissue Int,2017,101(2):182-192.

[7] 陶庆文,徐愿,孔维萍,等.基于名老中医经验传承寒热辨治强直性脊柱炎的临床研究[J].世界中西医结合杂志,2013,8(7):730-733.

[8] 孔维萍,朱笑夏,金玥,等.强直性脊柱炎寒、热不同证型的骨密度与疾病活动度特点[J].中日友好医院学报,2015,29(3):151-153,157.

[9] VAN DER LINDEN S, VALKENBURG H A, CATS A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria[J]. Arthritis Rheum,1984, 27(4):361-368.

[10] 中华医学会骨质疏松和骨矿盐疾病分会.原发性骨质疏松症诊治指南(2011年)[J].中华骨质疏松和骨矿盐疾病杂志,2011,4(1):2-17.

[11] 郑筱萸.中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,2002:119-123.

[12] CALIN A, GARRETT S, WHITELOCK H, et al. A new approach to defining functional ability in ankylosing spondylitis:the development of the Bath ankylosing spondylitis functional index[J]. J Rheumatol,1994,21(12):2281-2285.

[13] GARRETT S, JENKINSON T, KENNEDY L G, et al. A new approach to defining disease status in ankylosing spondylitis:the Bath ankylosing spondylitis disease activity index[J]. J Rheumatol, 1994,21(12):2286-2291.

[14] JENKINSON T R, MALLORIE P A, WHITELOCK H C, et al. Defining spinal mobility in ankylosing spondylitis (AS). The Bath AS metrology index[J]. J Rheumatol,1994,21(9):1694-1698.

[15] MACHADO P, NAVARRO-COMPÁN V, LANDEWÉ R, et al. Calculating the ankylosing spondylitis disease activity score if the conventional c-reactive protein level is below the limit of detection or if high-sensitivity c-reactive protein is used:an analysis in the DESIR cohort[J]. Arthritis Rheumatol,2015,67(2):408-413.

[16] CREEMERS M C, FRANSSEN M J, VAN’T HMA, et al. Assessment of outcome in ankylosing spondylitis:an extended radiographic scoring system[J]. Ann Rheum Dis,2005,64(1):127-129.

[17] 阎小萍,朱俊岭,颜珏,等.补肾强督方治疗强直性脊柱炎骨质疏松、骨量减少102例临床观察[J].中华中医药杂志,2007,22(8):571-573.

[18] BRIOT K, ROUX C. Inflammation, bone loss and fracture risk in spondyloarthritis[J]. RMD Open,2015,1(1):e000052.

[19] KARBERG K, ZOCHLING J, SIEPER J, et al. Bone loss is detected more frequently in patients with ankylosing spondylitis with syndesmophytes[J]. J Rheumatol,2005,32(7):1290-1298.

[20] ULU MA, ÇEVIK R, DILEK B. Comparison of PA spine, lateral spine, and femoral BMD measurements to determine bone loss in ankylosing spondylitis[J]. Rheumatol Int,2013,33(7):1705-1711.

[21] 甘晓维,陶庆文,王建明,等.阎小萍辨治强直性脊柱炎髋关节受累用药规律探析[J].北京中医药,2018,37(11):1039-1042.

[22] WANG D, HOU Z, GONG Y, et al. Bone edema on magnetic resonance imaging is highly associated with low bone mineral density in patients with ankylosing spondylitis[J]. PLoS One,2017,12(12):e0189569.

[23] BEEK K J, RUSMAN T, VAN DER WEIJDEN MAC, et al. Long-term treatment with TNF-alpha inhibitors improves bone mineral density but not vertebral fracture progression in ankylosing spondylitis[J]. J Bone Miner Res,2019,34(6):1041-1048.

[24] KLINGBERG E, LORENTZON M, MELLSTRÖM D, et al. Osteoporosis in ankylosing spondylitis - prevalence, risk factors and methods of assessment[J]. Arthritis Res Ther,2012,14(3):R108.

[25] WARD M M, DEODHAR A, AKL E A, et al. American College of Rheumatology/Spondylitis Association of America/ Spondyloarthritis Research and Treatment Network 2015 recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis[J]. Arthritis Rheumatol,2016,68(2):282-298.

[26] KIM H R, HONG Y S, PARK S H, et al. Low bone mineral density predicts the formation of new syndesmophytes in patients with axial spondyloarthritis[J]. Arthritis Res Ther,2018,20(1):231.

[27] ETF C, HHL T, LEE K H, et al. MRI inflammation of facet and costovertebral joints is associated with restricted spinal mobility and worsened functional status[J]. Rheumatology (Oxford), 2020. https://doi.org/10.1093/rheumatology/kez649.

[28] WANG R, WARD M M. Epidemiology of axial spondyloarthritis:an update[J]. Curr Opin Rheumatol,2018,30(2):137-143.

[29] CAPARBO V F, FURLAM P, CGS S, et al. Assessing bone impairment in ankylosing spondylitis (AS) using the trabecular bone score (TBS) and high-resolution peripheral quantitative computed tomography (HR-pQCT)[J]. Bone,2019,122:8-13.

相似文献/References:

[1]仇海华,单绍艳.自编功能锻炼操在强直性脊柱炎康复中的作用观察[J].中国中医药信息杂志,2010,17(5):64.
[2]张誉清,指导:张吉.张吉治疗股骨头坏死合并强直性脊柱炎验案1例[J].中国中医药信息杂志,2009,16(1):86.
 [J].zhongguo zhongyiyao xinxi zazhi,2009,16(9):86.
[3]黄传兵,陈晓雯,刘健,等.正清风痛宁缓释片联合柳氮磺胺吡啶治疗强直性脊柱炎临床研究[J].中国中医药信息杂志,2007,14(1):56.
 [J].zhongguo zhongyiyao xinxi zazhi,2007,14(9):56.
[4]马骁,李桂琴,王平,等.浅析阎小萍老师巧用对药治疗大[J].中国中医药信息杂志,2007,14(1):84.
 [J].zhongguo zhongyiyao xinxi zazhi,2007,14(9):84.
[5]汪东涛,沈鹰.中药熏蒸治疗强直性脊柱炎临床研究[J].中国中医药信息杂志,2009,16(7):11.
 WANG Dong-tao,SHEN Ying.Clinical Study of Chinese Medicine Fumigation in Treatment of Ankylosing Spondylitis[J].zhongguo zhongyiyao xinxi zazhi,2009,16(9):11.
[6]接力刚,沈鹰,孙维峰,等.局部注射正清风痛宁治疗强直性脊柱炎附着点炎临床观察[J].中国中医药信息杂志,2009,16(8):75.
 [J].zhongguo zhongyiyao xinxi zazhi,2009,16(9):75.
[7]周定华,周正球.益肾蠲痹方治疗强直性脊柱炎32例疗效观察[J].中国中医药信息杂志,2008,15(1):60.
 [J].zhongguo zhongyiyao xinxi zazhi,2008,15(9):60.
[8]陈志煌,韦嵩,沈鹰,等.正清风痛宁注射液关节腔内注射治疗强直性脊柱炎膝关节顽固性肿痛32例[J].中国中医药信息杂志,2008,15(3):65.
 [J].zhongguo zhongyiyao xinxi zazhi,2008,15(9):65.
[9]夏璇,指导:黄清春.黄清春中西医结合治疗强直性脊柱炎经验[J].中国中医药信息杂志,2011,18(3):96.[doi:10.3969/j.issn.1005-5304.2011.03.047]
 [J].zhongguo zhongyiyao xinxi zazhi,2011,18(9):96.[doi:10.3969/j.issn.1005-5304.2011.03.047]
[10]许凤全,冯兴华.强直性脊柱炎中医证候分型研究进展[J].中国中医药信息杂志,2008,15(8):104.
 [J].zhongguo zhongyiyao xinxi zazhi,2008,15(9):104.
[11]周时高,尤圣富,苏励,等.益肾温督小复方治疗肾虚督寒型强直性脊柱炎30例临床研究[J].中国中医药信息杂志,2009,16(11):11.
 ZHOU Shi-gao,YOU Sheng-fu,SU Li,et al.Clinical Study on Yishen Wendu Compound in Treatment of Ankylosing Spondylitis of Kidney Deficiency and Cold Governor Vessel Type[J].zhongguo zhongyiyao xinxi zazhi,2009,16(9):11.
[12]陈俊岚,周时高,曲环汝,等.强直性脊柱炎不同证型与病情活动的相关性分析[J].中国中医药信息杂志,2013,20(4):21.[doi:10.3969/j.issn.1005-5304.2013.04.009]
 [J].zhongguo zhongyiyao xinxi zazhi,2013,20(9):21.[doi:10.3969/j.issn.1005-5304.2013.04.009]

备注/Memo

基金项目:国家自然科学基金青年基金(81403378);北京市自然科学基金(7182148);中日友好医院青年科技英才培养计划(2014-QNYC-B-02)

更新日期/Last Update:

2020-08-20